Ekso Bionics Holdings Inc (EKSO)
0.89
+0.02
(+2.18%)
USD |
NASDAQ |
Nov 05, 16:00
0.89
0.00 (0.00%)
After-Hours: 19:17
Ekso Bionics Holdings Enterprise Value: 16.22M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 16.22M |
| November 01, 2024 | 16.58M |
| October 31, 2024 | 15.89M |
| October 30, 2024 | 17.57M |
| October 29, 2024 | 18.19M |
| October 28, 2024 | 21.92M |
| October 25, 2024 | 19.94M |
| October 24, 2024 | 19.50M |
| October 23, 2024 | 19.72M |
| October 22, 2024 | 19.94M |
| October 21, 2024 | 19.72M |
| October 18, 2024 | 20.16M |
| October 17, 2024 | 19.72M |
| October 16, 2024 | 20.82M |
| October 15, 2024 | 20.38M |
| October 14, 2024 | 20.16M |
| October 11, 2024 | 20.38M |
| October 10, 2024 | 19.50M |
| October 09, 2024 | 19.54M |
| October 08, 2024 | 19.50M |
| October 07, 2024 | 19.72M |
| October 04, 2024 | 19.94M |
| October 03, 2024 | 19.50M |
| October 02, 2024 | 19.28M |
| October 01, 2024 | 21.48M |
| Date | Value |
|---|---|
| September 30, 2024 | 22.58M |
| September 27, 2024 | 25.57M |
| September 26, 2024 | 25.14M |
| September 25, 2024 | 25.36M |
| September 24, 2024 | 26.22M |
| September 23, 2024 | 25.79M |
| September 20, 2024 | 25.79M |
| September 19, 2024 | 26.65M |
| September 18, 2024 | 25.57M |
| September 17, 2024 | 26.00M |
| September 16, 2024 | 26.22M |
| September 13, 2024 | 26.11M |
| September 12, 2024 | 25.57M |
| September 11, 2024 | 24.09M |
| September 10, 2024 | 25.57M |
| September 09, 2024 | 24.71M |
| September 06, 2024 | 24.49M |
| September 05, 2024 | 24.28M |
| September 04, 2024 | 24.23M |
| September 03, 2024 | 24.49M |
| August 30, 2024 | 21.85M |
| August 29, 2024 | 20.37M |
| August 28, 2024 | 20.01M |
| August 27, 2024 | 20.56M |
| August 26, 2024 | 20.01M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-13.52M
Minimum
Nov 30 2022
111.42M
Maximum
Feb 17 2021
16.95M
Average
16.17M
Median
Nov 09 2023
Enterprise Value Benchmarks
| Perspective Therapeutics Inc | 530.78M |
| Retractable Technologies Inc | -18.63M |
| InfuSystems Holdings Inc | 170.86M |
| Xtant Medical Holdings Inc | 101.94M |
| Catheter Precision Inc | 2.064M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.072M |
| Revenue (Quarterly) | 4.129M |
| Total Expenses (Quarterly) | 6.768M |
| EPS Diluted (Quarterly) | -0.10 |
| Gross Profit Margin (Quarterly) | 53.50% |
| Profit Margin (Quarterly) | -50.18% |
| Earnings Yield | -73.03% |
| Normalized Earnings Yield | -78.28 |